We currently do not have sufficient information about the CEO.
Key information
Mutsuo Kanzawa
Chief executive officer
n/a
Total compensation
CEO salary percentage
n/a
CEO tenure
44yrs
CEO ownership
3.7%
Management average tenure
4yrs
Board average tenure
11yrs
Recent management updates
Recent updates
CEO
Mutsuo Kanzawa (77 yo)
44yrs
Tenure
Mr. Mutsuo Kanzawa is Chief Executive Officer of Kissei Pharmaceutical Co. Ltd and served as its President since June 1992. Mr. Kanzawa has been the Chairman of Kissei Pharmaceutical Co. Ltd. since June 20...
Leadership Team
Name
Position
Tenure
Compensation
Ownership
Mutsuo Kanzawa
Chairman & CEO
no data
no data
3.73% $ 37.2m
Yasuo Takehana
President
4yrs
no data
0.042% $ 422.5k
Takahide Kitahara
GM of Financial Management Department
14yrs
no data
0.023% $ 234.1k
Tetsu Takayama
Executive MD
no data
no data
0.039% $ 390.6k
Yoshio Furihata
Senior Advisor & Director
16yrs
no data
0.032% $ 317.5k
Keiji Fukushima
Executive VP & Director
14yrs
no data
0.031% $ 310.3k
Hiroshi Noake
GM of Pharmaceutical Sales Headquarters & Director
4yrs
no data
0.0063% $ 62.5k
Keiji Miyazawa
GM of Research Division & Director
4yrs
no data
0.0056% $ 55.3k
Takayuki Komamura
Corporate Officer
no data
no data
no data
Nobuko Yanagi
Senior Director of General Administration Dept & Sustainability Management
less than a year
no data
no data
4.0yrs
Average Tenure
64yo
Average Age
Experienced Management: KSPH.F's management team is considered experienced (4 years average tenure).
Board Members
Name
Position
Tenure
Compensation
Ownership
Mutsuo Kanzawa
Chairman & CEO
44yrs
no data
3.73% $ 37.2m
Yasuo Takehana
President
14.4yrs
no data
0.042% $ 422.5k
Takahide Kitahara
GM of Financial Management Department
8yrs
no data
0.023% $ 234.1k
Tetsu Takayama
Executive MD
12yrs
no data
0.039% $ 390.6k
Yoshio Furihata
Senior Advisor & Director
18yrs
no data
0.032% $ 317.5k
Keiji Fukushima
Executive VP & Director
14yrs
no data
0.031% $ 310.3k
Hiroshi Noake
GM of Pharmaceutical Sales Headquarters & Director
4yrs
no data
0.0063% $ 62.5k
Keiji Miyazawa
GM of Research Division & Director
4yrs
no data
0.0056% $ 55.3k
Shigetaka Shimizu
Independent Outside Director
12yrs
no data
0.0099% $ 98.6k
Sayuri Uchikawa
Independent Outside Director
6yrs
no data
0.0051% $ 50.6k
Minoru Nomura
Independent Outside Director
10yrs
no data
0.014% $ 139.5k
Yoshinori Otsuki
Independent Outside Director
4yrs
no data
0.0051% $ 50.6k
11.0yrs
Average Tenure
66yo
Average Age
Experienced Board: KSPH.F's board of directors are seasoned and experienced ( 11 years average tenure).
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/06/10 18:49
End of Day Share Price
2026/03/13 00:00
Earnings
2026/03/31
Annual Earnings
2026/03/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Kissei Pharmaceutical Co., Ltd. is covered by 16 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.